A broad analysis of resistance development in the malaria parasite
Citations Over TimeTop 1% of 2016 papers
Abstract
Microbial resistance to chemotherapy has caused countless deaths where malaria is endemic. Chemotherapy may fail either due to pre-existing resistance or evolution of drug-resistant parasites. Here we use a diverse set of antimalarial compounds to investigate the acquisition of drug resistance and the degree of cross-resistance against common resistance alleles. We assess cross-resistance using a set of 15 parasite lines carrying resistance-conferring alleles in pfatp4, cytochrome bc1, pfcarl, pfdhod, pfcrt, pfmdr, pfdhfr, cytoplasmic prolyl t-RNA synthetase or hsp90. Subsequently, we assess whether resistant parasites can be obtained after several rounds of drug selection. Twenty-three of the 48 in vitro selections result in resistant parasites, with time to resistance onset ranging from 15 to 300 days. Our data indicate that pre-existing resistance may not be a major hurdle for novel-target antimalarial candidates, and focusing our attention on fast-killing compounds may result in a slower onset of clinical resistance.
Related Papers
- → Intraleucocytic malaria pigment and clinical severity of malaria in children(1998)110 cited
- → Diagnosis and treatment of imported and odyssean malaria(2014)3 cited
- Hearing loss: a possible consequence of malaria.(1995)
- ANALYSIS OF MALARIA EPIDEMIC BEFORE AND AFTER ERADICATION OF MALARIA IN TIANDENG COUNTY IN GUANGXI FROM 1980-2008(2011)
- → Single dose of small molecule cures malaria in mice(2021)